Globe Life Inc. (NYSE:GL) CFO Frank M. Svoboda sold 8,050 shares of the business’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $80.25, for a total transaction of $646,012.50. Following the completion of the sale, the chief financial officer now owns 10,000 shares in the company, valued at approximately $802,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

NYSE GL opened at $79.60 on Friday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.21. The company has a fifty day moving average of $75.06 and a two-hundred day moving average of $83.01. The firm has a market capitalization of $8.49 billion, a price-to-earnings ratio of 11.71 and a beta of 1.10. Globe Life Inc. has a 52 week low of $56.74 and a 52 week high of $111.43.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $1.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.53 by $0.12. The firm had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.16 billion. Globe Life had a net margin of 15.84% and a return on equity of 10.60%. During the same period in the previous year, the firm earned $1.67 earnings per share. Equities research analysts anticipate that Globe Life Inc. will post 6.88 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Monday, July 6th were paid a dividend of $0.1875 per share. This represents a $0.75 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date was Thursday, July 2nd. Globe Life’s dividend payout ratio is currently 11.11%.

Several institutional investors and hedge funds have recently modified their holdings of GL. Macquarie Group Ltd. boosted its stake in shares of Globe Life by 118.9% during the fourth quarter. Macquarie Group Ltd. now owns 248,125 shares of the company’s stock valued at $26,115,000 after purchasing an additional 134,800 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Globe Life during the fourth quarter valued at $2,637,000. Norges Bank purchased a new stake in shares of Globe Life during the fourth quarter valued at $120,501,000. State of Alaska Department of Revenue boosted its stake in shares of Globe Life by 8.4% during the first quarter. State of Alaska Department of Revenue now owns 62,831 shares of the company’s stock valued at $4,521,000 after purchasing an additional 4,867 shares during the period. Finally, Leith Wheeler Investment Counsel Ltd. boosted its stake in shares of Globe Life by 28.7% during the first quarter. Leith Wheeler Investment Counsel Ltd. now owns 74,024 shares of the company’s stock valued at $5,328,000 after purchasing an additional 16,500 shares during the period. 74.04% of the stock is owned by hedge funds and other institutional investors.

Several brokerages recently weighed in on GL. Zacks Investment Research cut shares of Globe Life from a “hold” rating to a “sell” rating and set a $76.00 price target on the stock. in a research report on Friday, June 26th. SunTrust Banks reduced their price target on shares of Globe Life from $108.00 to $79.00 and set a “hold” rating on the stock in a research report on Friday, April 24th. Piper Sandler reduced their price target on shares of Globe Life from $87.00 to $77.00 and set a “neutral” rating on the stock in a research report on Thursday, July 2nd. Credit Suisse Group reaffirmed a “buy” rating on shares of Globe Life in a research note on Thursday, July 23rd. Finally, Morgan Stanley lifted their price objective on shares of Globe Life from $78.00 to $80.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Five equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. Globe Life currently has an average rating of “Hold” and an average price target of $84.86.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Recommended Story: What is the Beige Book?

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.